Clinical Trials Browser

Phase 4 × Levofloxacin × 90 days × Clear all

NCT07320534 2026-01-08

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Phase 4 Not yet recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia